JFG
HAE icon

Jefferies Financial Group’s Haemonetics HAE Stock Holding History

Jefferies Financial Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,251
Closed -$397K – 1526
2025
Q1 		$397K Sell
6,251
-29,552
-83% -$2.01M ﹤0.01% 1125
2024
Q4 		$2.8M Buy
+35,803
New +$2.88M 0.02% 549
2023
Q4 		– Sell
-4,741
Closed -$425K – 1808
2023
Q3 		$425K Buy
+4,741
New +$423K ﹤0.01% 1129

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jefferies Financial Group's HAE Position: Q2 2025 in Review

Jefferies Financial Group sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 6,251 shares — an estimated $397K sold.

Jefferies Financial Group first reported a position in HAE in Q3 2023 and held it in 3 quarters. The position peaked at $2.8M in Q4 2024. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Jefferies Financial Group reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 6,251 Haemonetics shares in Q2 2025, an estimated $397K.
  • Jefferies Financial Group first reported a position in Haemonetics in Q3 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Haemonetics position peaked at $2.8M in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.